Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
08 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-reports-second-quarter-2024-financial-results-302218332.html
12 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-presents-first-preclinical-data-on-nktr-0165-a-tnfr2-agonist-antibody-being-developed-for-the-treatment-of-inflammatory-diseases-at-eular-2024-302170797.html
09 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-reports-first-quarter-2024-financial-results-302141700.html
24 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/24/2868445/0/en/Biolojic-Design-Announces-that-Nektar-Therapeutics-Has-Exercised-Its-License-Option-to-Develop-an-AI-Designed-Agonistic-Antibody-Targeting-TNFR2-for-the-Treatment-of-Autoimmune-Dis.html
05 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-initiation-of-phase-2b-clinical-study-evaluating-rezpegaldesleukin-in-patients-with-severe-to-very-severe-alopecia-areata-302079957.html
04 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-30-million-private-placement-financing-with-tcgx-302078499.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Nektar Therapeutics is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of Macrogol bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG SUBSTANCE bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG PRODUCT bulk with DMF offered by Nektar Therapeutics
Find a price of Amikacin bulk offered by Nektar Therapeutics
Find a price of Lysine bulk offered by Nektar Therapeutics
Find a price of Macrogol bulk offered by Nektar Therapeutics
Find a price of PEG2MAL40K bulk offered by Nektar Therapeutics
LOOKING FOR A SUPPLIER?